Discusses FDA Approval of TRYNGOLZA for Severe Hypertriglyceridemia and Acute Pancreatitis Risk Reduction June 24, ...
Analyst/Investor Day June 25, 2026 9:00 AM EDTCompany ParticipantsRyan GhazaeriSachin Lawande - President, CEO & ...
Showcase your company news with guaranteed exposure both in print and online Join us for an unforgettable evening of inspiration and empowerment at the Outstanding Women in… Tech Tomorrow 2026 offers ...
Foundation raised $6.4M for Passport Prime, a 'human authority' device CEO Zach Herbert says keeps people in control as AI ...
After several examples of undisclosed alterations in reagent suppliers’ antibody catalogues surfaced, researchers call for transparency to rebuild trust.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results